MicroStockProfit.com releases investment report on Cord Blood America

May 28 2010

MicroStockProfit.com announces an investment report featuring Cord Blood America Inc. (OTCBB:CBAI).  The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

The full report is available at: www.microstockprofit.com/lp/CBAI

Cord Blood America Inc. (CBAI) is engaged in the business of collecting, testing, processing and preserving umbilical cord blood.  The Company is primarily a holding company whose subsidiaries include Cord Partners Inc., CorCell Co. Inc., CorCell Ltd., CBA Professional Services Inc. D/B/A BodyCells Inc., CBA Properties Inc., Career Channel Inc., D/B/A Rainmakers International, and Family Marketing Inc.  In addition, the Company provides private cord blood stem cell preservation services to families in the United States.  It also engages in collecting, processing, and preserving peripheral blood and adipose tissue stem cells, which allows individuals to privately preserve their stem cells for potential future use in stem cell therapy.  Further, it creates direct response television and radio advertising campaigns, including media placement and commercial production; engages in the placement of advertising in television and radio outlets; and production of advertising content, including television commercials and radio copy.

Message Board Search for CBAI: http://www.boardcentral.com/boards/CBAI

In the report, the analyst notes:

"The Company announced that revenue decreased to $839,343 in the quarter ended March 31, 2010, compared to $941,938 in the same period in 2009.  This reflects continued de-emphasis of Rainmakers International, Cord Blood America's advertising company, with total focus on becoming a 'pure,' worldwide, stem cell company.  

"CBAI recently announced its stem cell processing and storage subsidiary, CorCell, is launching 'Afford-A-Cord,' which reduces the initial cost of storing umbilical cord blood stem cells from $2075 to $495 plus medical courier service."